“She totally tripped over saying "leronlimab" an
Post# of 148181
1. There are few who wouldn’t trip over saying leronlimab the first time if they haven’t heard it repeated a few times prior.
2. She’s a Doctor, not an investor, so her not mentioning Cytodyn by name is fine by me.
3. Lighten up a little. CYDY is going to increase and make those who sell a few shares this week a decent profit. Think about selling a few shares, getting a massage and a nice take-out dinner, and come back to the board nice and refreshed.